bokomslag Drug Utilization Evaluation in Chronic Obstructive Pulmonary Disease Patients
Kropp & själ

Drug Utilization Evaluation in Chronic Obstructive Pulmonary Disease Patients

Dr Nazia Lateef Amrohi Dr Husaini Begum Dr Madhavi Latha

Pocket

779:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 7-11 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

  • 52 sidor
  • 2020
The aim of the present work was to study the treatment pattern in the patients diagnosed with chronic obstructive pulmonary disease. The total number of drugs the patient received during their treatment period 19.20% of antibiotics are given to the patients , 18.70% of Corticosteroids , 18.10% of Short acting beta -2 agonist , 17.20% of Inhaled corticosteroids , 15.50% Methyxanthines , 6.90% of Systemic corticosteroids, 4.10% of Long acting beta -2 agonist , 0.30% of Secretolytic agents. According to route of administration the percentage was calculated as 23.70% of oral administrated drug, 37.98% are parenterally administered, 38.32% are inhalations.
  • Författare: Dr Nazia Lateef Amrohi, Dr Husaini Begum, Dr Madhavi Latha
  • Format: Pocket/Paperback
  • ISBN: 9786203198775
  • Språk: Engelska
  • Antal sidor: 52
  • Utgivningsdatum: 2020-12-31
  • Förlag: LAP Lambert Academic Publishing